• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by NeuroPace, Inc.

    NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace Announces RNS System Enhancements Designed to Streamline Care
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Participate in Upcoming Investor Conferences
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace Announces CEO Transition
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now Underway
    From NeuroPace, Inc.
    Via Business Wire
    Tickers NPCE
    NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022
    From NeuroPace, Inc.
    Via GlobeNewswire
    Tickers NPCE
    NeuroPace Announces First Patient Implanted in NAUTILUS Pivotal Study for the Treatment of Idiopathic Generalized Epilepsy (IGE)
    From NeuroPace, Inc.
    Via Business Wire
    Tickers NPCE
    NeuroPace Announces First Patient Treated in Pivotal Study Evaluating the RNS System in Adolescents
    From NeuroPace, Inc.
    Via Business Wire
    Tickers NPCE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.